http://www.unboundmedicine.com/medline/ebm/research/gemtuzumab_ozogamicinUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19915382/full_citation/Successful_induction_of_complete_remission_by_gemtuzumab_ozogamicin_following_chemotherapy_in_three_patients_with_relapsed_or_refractory_acute_myeloid_leukemia_Hirayama Y, Terui T, Koike K, et al. 
Successful induction of complete remission by gemtuzumab ozogamicin following chemotherapy in three patients with relapsed or refractory acute myeloid leukemia. [Journal Article]
Rinsho Ketsueki 2009 Aug; 50(8):663-5.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19904520/full_citation/Gemtuzumab_ozogamicin_induced_long_term_remission_in_a_woman_with_acute_myelomonocytic_leukemia_and_bone_marrow_relapse_following_allogeneic_transplantation_Sumi M, Ichikawa N, Nasu K, et al. 
Gemtuzumab ozogamicin-induced long-term remission in a woman with acute myelomonocytic leukemia and bone marrow relapse following allogeneic transplantation. [JOURNAL ARTICLE]
Int J Hematol 2009 Nov 11.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19860191/full_citation/[Combination_chemotherapy_for_acute_myeloid_leukemia]Nagai T 
[Combination chemotherapy for acute myeloid leukemia] [English Abstract, Journal Article]
Nippon Rinsho 2009 Oct; 67(10):1921-5.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19847200/full_citation/Influence_of_NPM1_and_FLT3_ITD_status_on_outcome_in_relapsed/refractory_AML_patients_receiving_salvage_therapy_including_gemtuzumab_ozogamicin_Chevallier P, Prebet T, Pigneux A, et al. 
Influence of NPM1 and FLT3-ITD status on outcome in relapsed/refractory AML patients receiving salvage therapy including gemtuzumab ozogamicin. [JOURNAL ARTICLE]
Leukemia 2009 Oct 22.
Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19844989/full_citation/Successful_combination_treatment_of_clofarabine_cytarabine_and_gemtuzumab_ozogamicin_in_adult_refractory_B_acute_lymphoblastic_leukemia_Papayannidis C, Derenzini E, Iacobucci I, et al. 
Successful combination treatment of clofarabine, cytarabine, and gemtuzumab-ozogamicin in adult refractory B-acute lymphoblastic leukemia. [JOURNAL ARTICLE]
Am J Hematol 2009 Sep 16.
Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19806665/full_citation/Salvage_therapy_for_acute_myeloid_leukemia_with_fludarabine_cytarabine_and_idarubicin_with_or_without_gemtuzumab_ozogamicin_and_with_concurrent_or_sequential_G_CSF_Martin MG, Augustin KM, Uy GL, et al. 
Salvage therapy for acute myeloid leukemia with fludarabine, cytarabine, and idarubicin with or without gemtuzumab ozogamicin and with concurrent or sequential G-CSF. [JOURNAL ARTICLE]
Am J Hematol 2009 Sep 11.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19804455/full_citation/Failure_of_three_novel_regimens_to_improve_outcome_for_patients_with_relapsed_or_refractory_acute_myeloid_leukaemia:_a_report_from_the_Eastern_Cooperative_Oncology_Group_Litzow MR, Othus M, Cripe LD, et al. 
Failure of three novel regimens to improve outcome for patients with relapsed or refractory acute myeloid leukaemia: a report from the Eastern Cooperative Oncology Group. [JOURNAL ARTICLE]
Br J Haematol 2009 Oct 5.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19788782/full_citation/Antibody_based_therapy_of_leukaemia_Morris JC, Waldmann TA 
Antibody-based therapy of leukaemia. [Journal Article, Research Support, N.I.H., Intramural]
Expert Rev Mol Med 2009.:e29.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19776761/full_citation/Analysis_of_factors_that_affect_in_vitro_chemosensitivity_of_leukaemic_stem_and_progenitor_cells_to_gemtuzumab_ozogamicin__Mylotarg__in_acute_myeloid_leukaemia_Jawad M, Seedhouse C, Mony U, et al. 
Analysis of factors that affect in vitro chemosensitivity of leukaemic stem and progenitor cells to gemtuzumab ozogamicin (Mylotarg) in acute myeloid leukaemia. [JOURNAL ARTICLE]
Leukemia 2009 Sep 24.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19776406/full_citation/Anthracycline_dose_intensification_in_acute_myeloid_leukemia_Fernandez HF, Sun Z, Yao X, et al. 
Anthracycline dose intensification in acute myeloid leukemia. [Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't]
N Engl J Med 2009 Sep 24; 361(13):1249-59.
Abstract | Full Citation | Find Related Articles